Medanta IPO
Medanta IPO — date, price band, lot size & details 2022
Medanta listed on 16 Nov 2022 at ₹401, 19.3% above the ₹336 issue price.
Global Health runs Medanta hospitals and is one of the largest private multi-specialty tertiary care providers in North and East India. Its total income was Rs 2,205.82 crore in FY2022.
Stock price
Medanta is listed — here is the live share price.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Timetable
Key dates from opening to listing. Today is 10 November.
- Open 03 Nov 2022
- Close 07 Nov 2022
- Allotment 11 Nov 2022
- Refund/credit 14 Nov 2022
- Listing 16 Nov 2022
Issue summary
The terms of the offer, as filed.
| IPO Dates | 3 to 7 Nov, 2022 |
|---|---|
| Price Band | ₹319 – ₹336 |
| Face Value | ₹2 |
| Lot Size | 44 Shares |
| Issue Size | ₹2205.57 Cr |
| Sale Type | Fresh capital cum OFS |
| Listing On | BSE, NSE |
| Registrar | KFin Technologies Limited |
| Min Investment | ₹ 14,784 |
Share of the offer set aside for each investor category, as stated in the offer document.
What will it cost me?
Bidding is in multiples of 44 shares at the ₹336 cut-off. Drag to size your application.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 44 | ₹14,784 |
| Retail (max) | 13 | 572 | ₹1,92,192 |
| S-HNI (min) | 14 | 616 | ₹2,06,976 |
| S-HNI (max) | 67 | 2,948 | ₹9,90,528 |
| B-HNI (min) | 68 | 2,992 | ₹10,05,312 |
Strengths & risks
Drawn from the offer document — the case for and against, side by side.
Strengths · 5
- 01Total income rose from Rs 1,544.27 crore in FY2020 to Rs 2,205.82 crore in FY2022.
- 02Profit after tax rose from Rs 36.33 crore in FY2020 to Rs 196.20 crore in FY2022.
- 03The source puts the EBITDA margin at 21.92%.
- 04Rs 375.00 crore of the fresh issue was planned for repaying subsidiary debt.
- 05Its 4 Medanta hospitals cover key specialties such as cardiac care, oncology and transplants, and the promoter sold no shares in the offer.
Risks · 5
- 01Rs 1,705.57 crore of the Rs 2,205.57 crore issue was offer for sale, so most of the money went to selling shareholders.
- 02The pre-issue P/E was 43.35 at the upper band of Rs 336, based on EPS of Rs 7.75.
- 03Profit fell to Rs 28.81 crore in FY2021 during the pandemic, so results can swing sharply.
- 04Total borrowing was Rs 794.45 crore on 30 June 2022.
- 05The promoter held only 35% before the issue and 33% after it.
Three years of numbers
All figures in ₹ crore, as reported in the Medanta offer document.
| Metric | 30 Jun 2022 | 31 Mar 2022 | 31 Mar 2021 | 30 Jun 2020 | 31 Mar 2020 |
|---|---|---|---|---|---|
| Assets | 3,221.94 | 3,145.52 | 2,694.11 | 2,855.11 | 2,666.29 |
| Total Income | 626.54 | 2,205.82 | 1,478.16 | 491.58 | 1,544.27 |
| Profit After Tax | 58.71 | 196.20 | 28.81 | 41.76 | 36.33 |
| NET Worth | 1,675.55 | 1,616.01 | 1,382.34 | 1,425.38 | 1,349.54 |
| Reserves and Surplus | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Borrowing | 794.45 | 837.86 | 644.60 | 725.07 | 621.94 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Valuation & key ratios
Ratios are for the latest full financial year reported in the Medanta RHP. EPS and P/E are post-issue — the table below carries the pre-issue comparison.
Medanta IPO Valuation
How the issue prices the company before and after the fresh shares are created.
| Valuation Metric | Pre-Issue | Post-Issue |
|---|---|---|
| EPS (₹) | ₹7.75 | ₹8.76 |
| P/E Ratio (x) | 43.35 | 38.36 |
| Market Cap at Offer Price (₹ Cr) | ₹2,545.36 | ₹2,251.89 |
Pre-issue figures use the shareholding reported in the RHP; post-issue figures use the shareholding once the fresh issue has created new shares. The two differ because of that dilution and because post-issue earnings per share are often annualised, so the change can run in either direction. Market capitalisation is calculated at the ₹336 offer price. Compare the post-issue P/E against listed peers before deciding — a premium there is growth you are paying for in advance.
Where the money goes
₹578.96 Cr of the issue is earmarked to named objects.
About the company
Its key specialties are cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology. It set up the Medanta Institutional Tissue Repository in 2017 for biomarker and tissue-based research.
It runs four hospitals at Gurugram, Indore, Ranchi and Lucknow. Its business was materially hit by the pandemic in Fiscal 2021. The promoter is Dr. Naresh Trehan.
The IPO was Rs 2,205.57 crore, with Rs 500.00 crore of fresh issue and Rs 1,705.57 crore of offer for sale. Rs 375.00 crore was planned for helping two subsidiaries repay borrowings.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
The bankers & the filings
Who is running the book, and the documents this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
JM Financial Ltd.
83 issues handledBest listing: Tempsens Instruments (India) (+111.3%). Weakest: Turtlemint Fintech Solutions (-10.4%).
Kotak Mahindra Capital Company Limited
58 issues handledBest listing: G R Infraprojects (+105.0%). Weakest: Rategain Travel Technologies (-15.3%).
Jefferies India Private Limited
21 issues handledBest listing: Nazara Technologies (+80.7%). Weakest: Turtlemint Fintech Solutions (-10.4%).
Credit Suisse Securities (India) Pvt. Ltd
8 issues handledBest listing: Zomato (+52.6%). Weakest: Star Health and Allied Insurance Company (-6.1%).
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Company contact
Frequently asked
What is the GMP of Medanta?
The current Grey Market Premium is ₹20, or 6% over the issue price.
What is the Medanta IPO price band?
₹319 to ₹336, on a face value of ₹2.
When is the allotment?
The basis of allotment is 11 November 2022, with listing on 16 November 2022.
How do I check allotment status?
On the IPO Guru allotment page or on the registrar's site — KFin Technologies Limited.
Every number here traces back to a filing.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Every number on this page is sourced from the RHP, BSE & NSE.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
